For example, a study reported that dihydroartemisinin-triggered ferroptosis of TAMs led to DNA damage and activation of the NF-κB signaling pathway to reprogram TAMs to an M1-like type, thus providing a new approach for lung cancer therapy (87). The gene discussed is NFKB1; the disease is lung cancer.